ZTS Zoetis Inc

Price (delayed)

$147.35

Market cap

$65.3B

P/E Ratio

25.32

Dividend/share

$1.93

EPS

$5.82

Enterprise value

$70.66B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 34% lower than the 5-year quarterly average of 38.6 and 18% lower than the last 4 quarters average of 30.7
Zoetis's EPS has increased by 14% YoY and by 4.3% QoQ
Zoetis's quick ratio has decreased by 47% YoY and by 3.3% QoQ

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
443.18M
Market cap
$65.3B
Enterprise value
$70.66B
Valuations
Price to earnings (P/E)
25.32
Price to book (P/B)
13.18
Price to sales (P/S)
6.99
EV/EBIT
20.06
EV/EBITDA
17.63
EV/Sales
7.53
Earnings
Revenue
$9.39B
Gross profit
$6.71B
Operating income
$3.53B
Net income
$2.61B
EBIT
$3.52B
EBITDA
$4.01B
Free cash flow
$2.22B
Per share
EPS
$5.82
EPS diluted
$5.81
Free cash flow per share
$4.99
Book value per share
$11.18
Revenue per share
$21.09
TBVPS
$23.92
Balance sheet
Total assets
$14.48B
Total liabilities
$9.5B
Debt
$6.79B
Equity
$4.98B
Working capital
$2.56B
Liquidity
Debt to equity
1.36
Current ratio
1.76
Quick ratio
0.88
Net debt/EBITDA
1.34
Margins
EBITDA margin
42.7%
Gross margin
71.5%
Net margin
27.8%
Operating margin
37.6%
Efficiency
Return on assets
18.3%
Return on equity
53.2%
Return on invested capital
28.1%
Return on capital employed
31.7%
Return on sales
37.5%
Dividend
Dividend yield
1.31%
DPS
$1.93
Payout ratio
33.2%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.6%
1 week
-0.02%
1 month
-6.62%
1 year
-21.75%
YTD
-9.56%
QTD
-5.51%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$9.39B
Gross profit
$6.71B
Operating income
$3.53B
Net income
$2.61B
Gross margin
71.5%
Net margin
27.8%
Zoetis's operating income has increased by 13% YoY and by 3.4% QoQ
The net income has grown by 11% YoY and by 3.7% from the previous quarter
The gross profit has grown by 8% YoY
The operating margin has increased by 7% YoY and by 2.2% from the previous quarter

Price vs fundamentals

How does ZTS's price correlate with its fundamentals

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
25.32
P/B
13.18
P/S
6.99
EV/EBIT
20.06
EV/EBITDA
17.63
EV/Sales
7.53
The P/E is 34% lower than the 5-year quarterly average of 38.6 and 18% lower than the last 4 quarters average of 30.7
Zoetis's EPS has increased by 14% YoY and by 4.3% QoQ
The stock's price to book (P/B) is 26% less than its 5-year quarterly average of 17.8 and 15% less than its last 4 quarters average of 15.5
ZTS's equity is up by 7% since the previous quarter
ZTS's price to sales (P/S) is 31% lower than its 5-year quarterly average of 10.1 and 16% lower than its last 4 quarters average of 8.3
ZTS's revenue is up by 5% YoY

Efficiency

How efficient is Zoetis business performance
ZTS's ROIC is up by 19% YoY and by 5% QoQ
The company's return on equity rose by 14% YoY and by 3.7% QoQ
ZTS's return on assets is up by 11% year-on-year and by 3.4% since the previous quarter
Zoetis's return on sales has increased by 7% YoY and by 2.2% QoQ

Dividends

What is ZTS's dividend history
DPS
$1.93
Dividend yield
1.31%
Payout ratio
33.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 52% greater than its total liabilities
The company's current ratio fell by 49% YoY
Zoetis's quick ratio has decreased by 47% YoY and by 3.3% QoQ
The debt is 36% higher than the equity
ZTS's equity is up by 7% since the previous quarter
Zoetis's debt to equity has decreased by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.